Meeting to be held in Denver on March 28 at 7pm hosted by BTIG.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NKTR:
- DraftKings, Eli Lilly downgraded: Wall Street’s top analyst calls
- Nektar Therapeutics: Rezpeg Clinical Momentum and Strong Cash Runway Underscore Attractive Risk‑Reward at Current Levels
- Nektar initiated with a Buy at TD Cowen
- Buy Rating on Nektar Driven by Rezpeg’s Blockbuster Potential in Atopic Dermatitis and Alopecia Areata
- Nektar price target raised to $123 from $102 at Citi